Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 January 2019 | Story Ruan Bruwer | Photo Varsity Cup
Varsity Cup
Shimlas scrumhalf, Rewan Kruger, played for the Junior Springboks last year and he was also jointly named Junior Player of the Year for the Shimlas alongside Lubabalo Dobela.

A fresh and inexperienced Shimla team, branded as the youngest squad ever, came two log points short of reaching the semi-finals of the Varsity Cup in last season's tournament. Ten of the players in the squad were still U19 last year. The 2018 rugby year proved to be a reconstructive one for the Shimlas after they parted ways with several members of their team in 2017.

After winning three of their first four encounters, including two away fixtures, the Shimlas were set for a spot in the semi-finals, which could possibly have been a home game. The three victories were against the defending champions Tuks by 19-17, 44-24 against Wits, and a 32-27 win over Ikeys.

The Shimlas played a total of 17 matches in 2018, claiming victory in 12. They finished fourth at the University Sport South Africa (USSA) tournament and won the Mangaung Metro league.

Johan Kotze, Shimla captain and prop, was titled ‘Senior Player of the Year’.

In the same breath, Lubabalo Dobela and Rewan Kruger, who both played for the Junior Springboks, were jointly selected as the ‘Junior Players of the Year’.

Vishuis was named the country’s best hostel rugby team for the third consecutive year. They defeated Patria of the North-West University in the finals by 55-29.

The UFS U20 team won all four of their matches in the group stage of the Young Guns competition before they lost to Tuks in the semi-final.

The Kovsie Sevens team won the bowl competition at the USSA tournament and at the Varsity Sevens they ended in 6th position.

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept